Dr. Oladapo O. Yeku, MD, PhD
- Medicare services, 2024
- 387
- Medicare patients, 2024
- 88
- Part D claims, 2024
- 129
- Publications
- 50
- Clinical trials
- 7
- Practice address
- 55 Fruit Street, Boston, MA 02114
- Practice phone
- Call (617) 726-2000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Yeku's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Oladapo O. Yeku is a hematologist and oncologist in Boston, Massachusetts
Dr. Yeku practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.
Dr. Yeku's NPI, 1477829489, was assigned on March 24, 2012. Dr. Yeku holds Massachusetts license 274176.
- NPI
- 1477829489NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2163778655
- NPI enumeration date
- March 24, 2012
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (617) 726-2000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 40
- Medical school graduation
- 2012
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Oladapo O. Yeku practices at Massachusetts General Hospital in Boston, Massachusetts
Dr. Yeku's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.
- Massachusetts General Hospital55 Fruit Street, Boston, MA 02114 · Suffolk CountyPhone(617) 726-2000
Source: Dmand AI Affiliation Data
Dr. Oladapo O. Yeku is affiliated with 3 sites of care and 4 medical groups
Dr. Yeku's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Yeku is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Hospital. Dmand AI also links Dr. Yeku to 3 more medical groups and 1 community health center, each named with a free account. Dr. Yeku's employer is on file too: a hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Oladapo O. Yeku's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yeku practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Massachusetts General Hospital | Available with a free account |
| +2 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Mass General Brigham and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Oladapo O. Yeku is one of 429 hematologists and oncologists in Massachusetts
Hematology and oncology is Dr. Yeku's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Yeku is licensed in Massachusetts.
Specialties and state licenses
- Hematology and oncology, MassachusettsPrimary
Hematologists and oncologists near Dr. Yeku
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Oladapo O. Yeku billed Medicare for 387 services in 2024
CMS data shows 387 Medicare services from Dr. Yeku across 5 procedure codes in 2024, for 88 Medicare patients. Medicare paid $33,669 for them.
Dr. Yeku's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4082024: 35014%
- Other services
- 2023: 02024: 37
Where Dr. Yeku's Medicare services took place, 2024
- In an office174%
- In a facility37096%
Dr. Yeku compared with the Massachusetts median for hematologists and oncologists, 2024
- Dr. Yeku
- Massachusetts median
- Medicare services
- 387vs 49522% below
- Medicare patients
- 88vs 20056% below
- Part D claims
- 11vs 15193% below
Medians across 415 hematologists and oncologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Yeku's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Yeku?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Yeku and other hematologists and oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Oladapo O. Yeku treated 88 Medicare patients in 2024, average age 74
CMS counts 88 Medicare patients who saw Dr. Yeku in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 65% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Yeku's median patient age at 72, with 65% women.
Dr. Yeku's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Yeku's Medicare patients, 2024
- High blood pressure75%
- High cholesterol65%
- Cancer53%
- Anxiety43%
- Arthritis43%
- Mood disorders36%
- Chronic kidney disease33%
- Depression31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Yeku's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women65%
- Men35%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Oladapo O. Yeku wrote 129 Medicare Part D claims in 2024
In 2024, Dr. Yeku wrote 129 Medicare Part D claims for 30 patients. 78% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $18 in total drug cost. In 2023, CMS named 34 claims across 3 drugs.
Dr. Yeku's Part D claims by kind of drug, 2024
- Generic101 claims78%
- Brand-name and other28 claims22%
Dr. Yeku's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 342024: 1168%
Drugs named by CMS: 1 in 2024, 3 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Oladapo O. Yeku offers telehealth to Medicare patients
Dr. Yeku accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yeku as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Oladapo O. Yeku has 50 publications on record
Dmand AI links 50 papers to Dr. Yeku, published from 2013 to 2025. 2024 was the busiest year, with 15. The most frequent topics are Ovarian Neoplasms, Cell Line, Tumor and Antineoplastic Combined Chemotherapy Protocols. Dr. Yeku has published most often in N Engl J Med. Dr. Yeku's most frequent co-authors are David R. Spriggs, MD, Richard T. Penson, MD and Sara Bouberhan, MD.
Dr. Yeku's papers by year, 2015 to 2025
Topics Dr. Yeku writes about most
- Ovarian Neoplasms
- Cell Line, Tumor
- Antineoplastic Combined Chemotherapy Protocols
- T-Lymphocytes
- Endometrial Neoplasms
- Antibodies, Monoclonal
- CA-125 Antigen
- Immunotherapy, Adoptive
Dr. Yeku's most frequent co-authors
- David R. Spriggs, MD10 shared papers
- Richard T. Penson, MD5 shared papers
- Sara Bouberhan, MD4 shared papers
Recent publications by Dr. Yeku
J Immunother Cancer
See who Dr. Yeku researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Yeku works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Oladapo O. Yeku has worked on 7 clinical trials
Dmand AI links Dr. Yeku to 7 clinical trials, 3 of them phase 2 studies. 6 are still active or recruiting. Conditions studied include Endometrial Neoplasms, Fallopian Tube Diseases and Colonic Neoplasms. Regeneron Pharmaceuticals sponsors the most, 2. Open Payments lists research payments to Dr. Yeku that name 2 trials.
Clinical trials with Dr. Yeku by phase
- 1Phase 1: 1 trial
- 3Phase 2: 3 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Yeku's trials
- Endometrial Neoplasms
- Fallopian Tube Diseases
- Colonic Neoplasms
- Disease Attributes
- Vulvar Neoplasms
Investigators on the most trials with Dr. Yeku
- Sara Bouberhan, MD2 shared trials
- Roisin Eilish O'Cearbhaill, MBCHB2 shared trials
- Joyce N. Barlin, MD1 shared trial
Recent clinical trials with Dr. Yeku
A Phase 2 Study of Combined Chemo-immunotherapy With Cisplatin-pembrolizumab and Radiation for Unresectable Vulvar Squamous Cell Carcinoma (opens in a new tab)
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Patients With Select Solid Tumors (opens in a new tab)
A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) (opens in a new tab)
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Oladapo O. Yeku received $5,905 in industry payments from 2020 to 2025
CMS Open Payments shows 5 general payments to Dr. Yeku from 5 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 97% of the total. Aadi Bioscience, Inc. paid the most, $1,500. It also lists 15 research payments totaling $3,718 from 2021 to 2025, naming 2 clinical trials.
General payments to Dr. Yeku by program year, 2020 to 2025
General payments to Dr. Yeku by kind, 2020 to 2025
- Consulting fees$5,75597%
- Food and beverage$1503%
Companies that paid Dr. Yeku the most, 2020 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Oladapo O. Yeku's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Oladapo O. Yeku
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Oladapo O. Yeku's NPI number?
Dr. Oladapo O. Yeku's NPI number is 1477829489. It was assigned on March 24, 2012, and it is active in the NPI Registry.
What kind of doctor is Dr. Oladapo O. Yeku?
Dr. Oladapo O. Yeku is a hematologist and oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Oladapo O. Yeku practice?
Dr. Yeku practices at 55 Fruit Street, Boston, MA 02114. Dr. Yeku's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dmand AI also links Dr. Yeku to 3 medical groups and 1 community health center.
What is Dr. Oladapo O. Yeku's office phone number?
The practice phone on file for Dr. Yeku is (617) 726-2000.
What is Dr. Oladapo O. Yeku's medical license number?
Dr. Yeku holds Massachusetts license 274176.
Which hospitals is Dr. Oladapo O. Yeku affiliated with?
Dr. Yeku practices at Massachusetts General Hospital in Boston, Massachusetts. Dr. Yeku is also affiliated with Brigham and Women's Hospital.
What medical group is Dr. Oladapo O. Yeku part of?
Dr. Yeku is linked to Massachusetts General Hospital. Dmand AI links Dr. Yeku to 3 more medical groups.
Does Dr. Oladapo O. Yeku accept Medicare?
Yes. CMS data shows Dr. Yeku billed Medicare for 387 services in 2024, and Dr. Yeku accepts Medicare assignment.
Does Dr. Oladapo O. Yeku offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Yeku as offering telehealth services.
How many Medicare patients does Dr. Oladapo O. Yeku see?
CMS counts 88 Medicare patients who saw Dr. Yeku in 2024, with an average age of 74.
Show 6 more questionsShow fewer questions
What services does Dr. Oladapo O. Yeku bill to Medicare?
In 2024, Dr. Yeku's most billed Medicare services were office visit, established patient (99215), hospital inpatient care (99232) and office visit, established patient (99214).
What drugs does Dr. Oladapo O. Yeku prescribe most?
In 2024 Medicare Part D data, Dr. Yeku's most prescribed drugs by claims were Lorazepam.
Has Dr. Oladapo O. Yeku received payments from drug or device companies?
CMS Open Payments shows $5,905 in general payments to Dr. Yeku from 5 companies from 2020 to 2025. The largest total came from Aadi Bioscience, Inc.
How long has Dr. Oladapo O. Yeku been practicing?
Dr. Yeku graduated from medical school in 2012, 14 years ago.
Does Dr. Oladapo O. Yeku do research?
Dmand AI links 50 publications to Dr. Yeku, published from 2013 to 2025. Dr. Yeku has worked on 7 clinical trials.
Who does Dr. Oladapo O. Yeku publish with?
Dr. Yeku's most frequent co-authors are David R. Spriggs, MD (10 shared papers), Richard T. Penson, MD (5 shared papers) and Sara Bouberhan, MD (4 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card